Zealand Pharma A/S (ZEAL): key financial figures for fiscal year 2025 (in DKK), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2025)
- kr 9.2B
- Net Income/Loss (FY2025)
- kr 6.5B
- Total Assets (FY2025)
- kr 15.9B
- Total Equity (FY2025)
- kr 14.8B
- Cash Flows from Operating Activities (FY2025)
- kr 6.5B
Source: Zealand Pharma A/S annual_report filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
